PIM-1 inhibition with AZD1208 to prevent osimertinib-induced resistance in EGFR-mutation positive non-small cell lung cancer

  • Bracht J
  • Karachaliou N
  • Berenguer J
  • et al.
N/ACitations
Citations of this article
8Readers
Mendeley users who have this article in their library.

Cite

CITATION STYLE

APA

Bracht, J. W. P., Karachaliou, N., Berenguer, J., Fernandez-Bruno, M., Filipska, M., Pedraz-Valdunciel, C., … Rosell, R. (2019). PIM-1 inhibition with AZD1208 to prevent osimertinib-induced resistance in EGFR-mutation positive non-small cell lung cancer. Journal of Cancer Metastasis and Treatment, 2019. https://doi.org/10.20517/2394-4722.2018.111

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free